Latest News

Micronoma Raises $3.5 Million in Convertible Note Financing

Investors more than double funding base for cancer microbiome diagnostic company to accelerate go-to-market timeline six months after seed February 17, 2021 -- San Diego, Calif. Micronoma, the first cancer detection biotech company that utilizes signals from the tumor-related microbiome to diagnose cancer at an early stage with liquid biopsy technology, today announced the closing of $3.5 million in convertible debt financing. The contributions came from existing investor, US-based SymBiosis,...

Upcoming Conferences

Inaugural Microbiome Leaders Conference 3/24 - Finding New Avenues of Cancer Cures and Diagnostic by Studying Tissue and Circulating Microbiome

Precision Medicine World Conference 2021 6/16-6/18 - "Cancer Microbiome and Diagnostic Application"

Microbiome Movement, Drug Development 6/26-7/1 - "Tissue and Circulating microbiomes - the new frontier"

Micronoma Establishes Scientific Advisory Board

International oncology, microbiome and drug discovery expertise synergize to guide unique early cancer detection startup SAN DIEGO, Dec. 9, 2020 /PRNewswire/ -- Micronoma, the first cancer detection biotech company that uses signals from the tumor-related microbiome to diagnose cancer at an early stage with minimally-invasive liquid biopsy technology, today announced the formation of its scientific advisory board (SAB). The SAB is composed of industry experts and key opinion leaders for...

Micronoma Expands Executive Team and Operations

Innovative early cancer detection company establishes headquarters and adds three key executive positions San Diego, Calif. (November 5, 2020). Micronoma, an early-stage cancer detection biotech company seeking to develop and commercialize a minimally-invasive, unique...

Micronoma Appoints Magda Marquet Chairman of the Board

Biotech maven joins early-stage cancer detection company utilizing innovative microbiome analysis SAN DIEGO, Sept. 30, 2020 /PRNewswire/ -- Micronoma, an early stage cancer-detection start-up seeking to develop and commercialize a minimally-invasive, unique...

Micronoma Launches with $3 Million Seed Funding

For Immediate Release Media Contact: Celia Sepulveda, Celia.Sepulveda@Micronoma.com, 858.337.1326   Micronoma Launches with $3 Million Seed Funding   First early cancer-detection company to use microbial biomarkers in diagnostics   San Diego, Calif....

Microbial DNA in Patient Blood May be Tell-Tale Sign of Cancer

From a simple blood draw, microbial DNA may reveal who has cancer and which type, even at early stages When Gregory Poore was a freshman in college, his otherwise healthy grandmother was shocked to learn that she had late-stage pancreatic cancer. The condition was...

Contact Us

If you have questions or would like to learn more, please email us at info@micronoma.com or contact us.

Micronoma
6342 Ferris Square
San Diego, CA 92121